Prescription drug · ANDA
Phenytoin NDC 0121-0892
Phenytoin 125 mg/5mL · Suspension · Oral · PAI Holdings, LLC dba PAI Pharma
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0121-0892-63 | 0012108926300121089263 | 4 mL in 1 CUP, UNIT-DOSE (0121-0892-63)Marketed from Apr 8, 2004 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Phenytoin
- Generic name (nonproprietary)
- phenytoin
- Active ingredients
- Phenytoin — 125 mg/5mL
- Dosage form
- Suspension
- Route
- Oral
- Labeler
- PAI Holdings, LLC dba PAI PharmaNDC labeler code 0121
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040521
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 1A2 Inducers (Mechanism)Cytochrome P450 2B6 Inducers (Mechanism)Cytochrome P450 2C19 Inducers (Mechanism)Cytochrome P450 2C8 Inducers (Mechanism)Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 2D6 Inducers (Mechanism)Cytochrome P450 3A Inducers (Mechanism)Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 0121-0892_4daa397f-237b-4327-91bd-d86b19e4b9b2SPL ID 4daa397f-237b-4327-91bd-d86b19e4b9b2SPL set ID f2c74e35-ed8d-4ea6-b7a5-7be0b0155c15RxCUI 1313112UNII 6158TKW0C5
- Pharmacologic class
- Anti-epileptic Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400121089263followed by a unit qualifier and the quantityPackage 00121-0892-63. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Phenytoin oral suspension is indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures. Phenytoin oral suspension is indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0121-0892
- What is NDC 0121-0892?
- 0121-0892 is the product NDC for Phenytoin, Phenytoin 125 mg/5mL suspension, listed with the FDA by PAI Holdings, LLC dba PAI Pharma. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Phenytoin.
- What is the active ingredient?
- Phenytoin.
- Who is the labeler?
- PAI Holdings, LLC dba PAI Pharma, NDC labeler code 0121. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Phenytoin?
- 10 other product NDCs are listed under this name. See all Phenytoin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Phenytoin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Phenytoin | Phenytoin 50 mg/1 | Tablet, ChewableOral | Rising Pharma Holdings, Inc. | 64980-573 | 64980-0573-01 |
| Phenytoin | Phenytoin 125 mg/5mL | SuspensionOral | Mylan Pharmaceuticals Inc. | 59762-0531 | 59762-0531-02 |
| Phenytoin | Phenytoin 125 mg/5mL | SuspensionOral | American Health Packaging | 60687-275 | 60687-0275-66 |
| Phenytoin | Phenytoin 50 mg/1 | Tablet, ChewableOral | REMEDYREPACK INC. | 70518-0841 | 70518-0841-0070518-0841-03 |
| Phenytoin | Phenytoin 50 mg/1 | Tablet, ChewableOral | American Health Packaging | 60687-156 | 60687-0156-25 |
| Phenytoin | Phenytoin 50 mg/1 | Tablet, ChewableOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8623 | 00615-8623-39 |
| Phenytoin | Phenytoin 50 mg/1 | Tablet, ChewableOral | Major Pharmaceuticals | 0904-7199 | 00904-7199-07 |
| Phenytoin | Phenytoin 50 mg/1 | Tablet, ChewableOral | Sun Pharmaceutical Industries, Inc. | 51672-4146 | 51672-4146-0151672-4146-0351672-4146-06 |
| Phenytoin | Phenytoin 125 mg/5mL | SuspensionOral | ATLANTIC BIOLOGICALS CORP. | 17856-4070 | 17856-4070-01 |
| Phenytoin | Phenytoin 125 mg/5mL | SuspensionOral | Sun Pharmaceutical Industries, Inc. | 51672-4069 | 51672-4069-02 |
Other NDCs under ANDA 040521
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Phenytoin | Phenytoin 125 mg/5mL | SuspensionOral | ATLANTIC BIOLOGICALS CORP. | 17856-4070 |
| Phenytoin | Phenytoin 125 mg/5mL | SuspensionOral | Sun Pharmaceutical Industries, Inc. | 51672-4069 |
| Phenytoin | Phenytoin 125 mg/5mL | SuspensionOral | American Health Packaging | 60687-275 |